Fujian Aonong Biological Technology Group Incorporation Ltd (SHG:603363) — Market Cap & Net Worth
Market Cap & Net Worth: Fujian Aonong Biological Technology Group Incorporation Ltd (603363)
Fujian Aonong Biological Technology Group Incorporation Ltd (SHG:603363) has a market capitalization of $1.17 Billion (CN¥8.00 Billion) as of September 24, 2026. Listed on the SHG stock exchange, this China-based company holds position #8297 globally and #1951 in its home market, demonstrating a -2.01% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Fujian Aonong Biological Technology Group Incorporation Ltd's stock price CN¥2.93 by its total outstanding shares 2731061826 (2.73 Billion). Also see Fujian Aonong Biological Technology Grou assets under control for a full breakdown of the balance sheet.
Fujian Aonong Biological Technology Group Incorporation Ltd Market Cap History: 2017 to 2026
Fujian Aonong Biological Technology Group Incorporation Ltd's market capitalization history from 2017 to 2026. Data shows change from $4.96 Billion to $1.17 Billion (-6.16% CAGR). Also see how efficiently does Fujian Aonong Biological Technology Grou generate cash for how efficiently the company converts equity into cash flow.
Fujian Aonong Biological Technology Group Incorporation Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Fujian Aonong Biological Technology Group Incorporation Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check today's stock price for Fujian Aonong Biological Technology Grou for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.22x
Fujian Aonong Biological Technology Group Incorporation Ltd's market cap is 0.22 times its annual revenue
Latest Price to Earnings (P/E) Ratio
23.73x
Fujian Aonong Biological Technology Group Incorporation Ltd's market cap is 23.73 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $4.96 Billion | $4.90 Billion | $108.12 Million | 1.01x | 45.92x |
| 2018 | $2.53 Billion | $5.76 Billion | $30.13 Million | 0.44x | 83.99x |
| 2019 | $4.78 Billion | $5.79 Billion | $29.16 Million | 0.83x | 163.82x |
| 2020 | $4.88 Billion | $11.52 Billion | $572.99 Million | 0.42x | 8.52x |
| 2021 | $5.08 Billion | $18.04 Billion | -$1.52 Billion | 0.28x | N/A |
| 2022 | $5.15 Billion | $21.61 Billion | -$1.04 Billion | 0.24x | N/A |
| 2023 | $2.43 Billion | $19.46 Billion | -$3.65 Billion | 0.12x | N/A |
| 2024 | $1.41 Billion | $8.76 Billion | $579.35 Million | 0.16x | 2.44x |
| 2025 | $1.84 Billion | $8.47 Billion | $77.62 Million | 0.22x | 23.73x |
Competitor Companies of 603363 by Market Capitalization
Companies near Fujian Aonong Biological Technology Group Incorporation Ltd in the global market cap rankings as of September 24, 2026. Review tangible equity quality of Fujian Aonong Biological Technology Grou to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Fujian Aonong Biological Technology Group Incorporation Ltd by market ranking:
- Muyuan Foodstuff Co Ltd (SHE:002714): Ranked #825 globally with a market cap of $33.46 Billion USD ( CN¥228.67 Billion CNY).
- Archer-Daniels-Midland Company (NYSE:ADM): Ranked #827 globally with a market cap of $33.40 Billion USD.
- Bunge Limited (NYSE:BG): Ranked #1228 globally with a market cap of $21.29 Billion USD.
- Tyson Foods Inc (NYSE:TSN): Ranked #1669 globally with a market cap of $14.60 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #825 | Muyuan Foodstuff Co Ltd | SHE:002714 | $33.46 Billion | CN¥41.86 |
| #827 | Archer-Daniels-Midland Company | NYSE:ADM | $33.40 Billion | $82.34 |
| #1228 | Bunge Limited | NYSE:BG | $21.29 Billion | $110.00 |
| #1669 | Tyson Foods Inc | NYSE:TSN | $14.60 Billion | $51.82 |
Fujian Aonong Biological Technology Group Incorporation Ltd Historical Marketcap From 2017 to 2026
Between 2017 and today, Fujian Aonong Biological Technology Group Incorporation Ltd's market cap moved from $4.96 Billion to $ 1.17 Billion, with a yearly change of -6.16%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥1.17 Billion | -36.44% |
| 2025 | CN¥1.84 Billion | +30.23% |
| 2024 | CN¥1.41 Billion | -41.68% |
| 2023 | CN¥2.43 Billion | -52.91% |
| 2022 | CN¥5.15 Billion | +1.50% |
| 2021 | CN¥5.08 Billion | +3.97% |
| 2020 | CN¥4.88 Billion | +2.21% |
| 2019 | CN¥4.78 Billion | +88.76% |
| 2018 | CN¥2.53 Billion | -49.03% |
| 2017 | CN¥4.96 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 23rd, 2026 the market cap of Fujian Aonong Biological Technology Group Incorporation Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.17 Billion USD |
| MoneyControl | $1.17 Billion USD |
| MarketWatch | $1.17 Billion USD |
| marketcap.company | $1.17 Billion USD |
| Reuters | $1.17 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Fujian Aonong Biological Technology Group Incorporation Ltd
Fujian Aonong Biological Technology Group Incorporation Limited engages in the feed, pig farming, food, supply chain services, and other businesses in China and internationally. It researches and develops, produces, and sells feed products, such as pig feed, poultry feed, aquatic feed, ruminant, and other products; and operates pig breeding farms. The company also engages in the pig slaughtering … Read more